Related content

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

By Romero Pedro   Cerottini Jean-Charles   Speiser Daniel  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite

Reversioninducing cysteinerich protein with Kazal motifs gene expression and its clinical significance in peripheral T-cell lymphoma

By        

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1867-1871

Spandidos Publications

Access to resources Recommend Favorite

Generation of dendritic cell–tumor cell hybrids by electrofusion for clinical vaccine application

By Trevor Katrina   Cover Cathleen   Ruiz Yvette   Akporiaye Emmanuel   Hersh Evan   Landais Didier   Taylor Rachel   King Alan   Walters Richard  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 705-714

Springer Publishing Company

Access to resources Recommend Favorite

Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning

By Jäger Dirk   Taverna Christian   Zippelius Alfred   Knuth Alexander  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 144-147

Springer Publishing Company

Access to resources Recommend Favorite

Expression of Carbohydrate Antigens in Human Esophageal Squamous Cell Carcinoma: Prognostic Application and Its Diagnostic Implications

By Faried Ahmad   Kimura Hitoshi   Faried Leri   Usman Nurhayat   Miyazaki Tatsuya   Kato Hiroyuki   Yazawa Shin   Kuwano Hiroyuki  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 960-967

Springer Publishing Company

Access to resources Recommend Favorite